ストックスクリーナーアプリを入手
80.04
5.57%
4.22
プレマーケット:
80.00
-0.04
-0.05%
前日終値:
$75.82
開ける：
$75.47
24時間の取引高:
10.40M
Relative Volume:
2.56
時価総額：
$31.26B
収益：
$3.95B
当期純損益:
$680.80M
株価収益率:
87.96
EPS:
0.91
ネットキャッシュフロー:
$535.00M
1週間 パフォーマンス:
+3.69%
1か月 パフォーマンス:
+6.38%
6か月 パフォーマンス:
-31.04%
1年 パフォーマンス:
-31.38%
1日の値動き範囲:
$75.47
$81.51
1週間の範囲:
$74.50
$81.51
52週間の値動き範囲:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
DXCM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
80.04 | 31.26B | 3.95B | 680.80M | 535.00M | 1.67 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 開始されました | Redburn Atlantic | Neutral |
| 2024-03-12 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-04-17 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2023-01-26 | 開始されました | Wolfe Research | Outperform |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-15 | 開始されました | Bernstein | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-18 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-28 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2021-01-06 | アップグレード | UBS | Neutral → Buy |
| 2020-10-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-14 | 開始されました | Wells Fargo | Equal Weight |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-11-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-10-23 | 開始されました | Stifel | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-09-12 | アップグレード | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-07-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
| 2018-05-03 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-04-04 | 開始されました | Goldman | Sell |
| 2018-04-04 | 開始されました | Guggenheim | Neutral |
| 2018-03-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | ダウングレード | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Dexcom Inc (DXCM) 最新ニュース
Principal Financial Group Inc. Has $45.53 Million Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc.DXCM - Business Wire
1 Reason to Sell DexCom Stock, and 1 Reason to Buy - sharewise
DexCom (NASDAQ:DXCM) Trading 7.3% HigherStill a Buy? - MarketBeat
Orion Portfolio Solutions LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Ōura closes $200M series D, Dexcom invests $75M - BioWorld Online
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada - MSN
Oura boosts valuation to $5.2B in latest funding round (NASDAQ:DXCM) - Seeking Alpha
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement - Business Wire
UPC latest: CoA decision has retroactive effect | Dexcom defeat | 2025 predictions - Managing Intellectual Property
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024DXCM - The Eastern Progress Online
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Dexcom implements GenAI into glucose biosensor devices - Yahoo Finance
Dexcom adds generative AI to over-the-counter CGMs - MedTech Dive
Insiders At DexCom Sold US$18m In Stock, Alluding To Potential Weakness - Simply Wall St
AI-Driven Glucose Biosensing: Dexcom’s (DXCM) Path To A Comeback - Yahoo Finance
Dexcom director Bridgette Heller sells shares for $76,870 By Investing.com - Investing.com Australia
Dexcom's COO Jacob Leach sells $57,191 in stock By Investing.com - Investing.com South Africa
Dexcom director Bridgette Heller sells shares for $76,870 - Investing.com India
Dexcom's COO Jacob Leach sells $57,191 in stock - Investing.com
Dexcom launches generative AI platform for glucose biosensing - Mass Device
Dexcom Rolls Out GenAI Platform for Stelo CGM - MPO-mag
Dexcom Launches First-Ever GenAI Platform for Glucose Monitoring, Partners with Google Cloud - StockTitan
Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM - Yahoo Finance
Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Dexcom shares up as Diabetes Association updates guidelines - MSN
Lord Abbett & CO. LLC Sells 23,004,568 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
MML Investors Services LLC Reduces Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - MSN
DexCom, Inc. (NASDAQ:DXCM) Short Interest Update - MarketBeat
DexCom's SWOT analysis: cgm maker faces challenges amid stock volatility - Investing.com
Tidal Investments LLC Raises Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
World Investment Advisors LLC Purchases Shares of 35,066 DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Virtu Financial LLC Buys New Shares in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
M&T Bank Corp Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Stifel Financial Corp Sells 24,859 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Brokerages Set DexCom, Inc. (NASDAQ:DXCM) Target Price at $98.00 - MarketBeat
DexCom (NASDAQ:DXCM) Price Target Raised to $94.00 - Defense World
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom - The Eastern Progress Online
DexCom Stock Price | DXCM Stock Quote, News, and History - Markets Insider
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Geode Capital Management LLC - MarketBeat
DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit - The Eastern Progress Online
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc.DXCM - The Eastern Progress Online
Continuous Glucose Monitoring Devices Market Set to Witness Significant Growth by 2024-2031: Dexcom, Inc., - EIN News
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
DexCom Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Gross Law Firm Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineDXCM - Kilgore News Herald
European court rules in favor of Abbott in Dexcom CGM patent spat - Mass Device
Public Employees Retirement System of Ohio Has $9.78 Million Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Quantinno Capital Management LP Decreases Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Dexcom Inc (DXCM) 財務データ
収益
当期純利益
現金流量
EPS
Dexcom Inc (DXCM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sylvain Jereme M | EVP, Chief Financal Officer |
Dec 16 '24 |
Sale |
76.87 |
744 |
57,191 |
80,030 |
| Leach Jacob Steven | EVP, Chief Operating Officer |
Dec 16 '24 |
Sale |
76.87 |
744 |
57,191 |
264,171 |
| Heller Bridgette P | Director |
Dec 16 '24 |
Sale |
76.87 |
1,000 |
76,870 |
23,349 |
1.91%
大文字化:
|
ボリューム (24 時間):